Translational Neuroimmunology in Multiple Sclerosis: From Disease Mechanisms to Clinical Applications
Editat de Ruth Arnon, Ariel Milleren Limba Engleză Hardback – 10 aug 2016
Translational Neuroimmunology in Multiple Sclerosis provides an overview of recent findings and knowledge of the neuroimmunology of multiple sclerosis, from experimental models and the human disease to the translation of this research to immunotherapeutic strategies. Chapters describe genetic and environmental factors underlying the disease pathogenesis of MS as a basis for development of immunotherapies, immunological markers of disease activity, pharmacogenetics, and responses to therapy. Immunomodulatory therapies currently in practice and future therapeutic strategies on the horizon—such as neuroprotective strategies, stem cells, and repair promotion—are discussed. Contributed by renowned leaders in the field, this cross-disciplinary volume is a great resource for basic scientists and clinical practitioners in neuroscience, neurology, immunology, pharmacology, and in-drug development.
- Provides an overview of recent findings and knowledge of the neuroimmunology of multiple sclerosis and the translation of this research to immunotherapy treatment
- Edited by renowned leaders in the field of neuroimmunology and multiple sclerosis
- Contains the latest resource material for basic and clinical scientists and practitioners in neuroscience, neurology, immunology, and pharmacology
- 2017 BMA Medical Book Awards Highly Commended in Neurology
Preț: 583.12 lei
Preț vechi: 675.39 lei
-14% Nou
Puncte Express: 875
Preț estimativ în valută:
111.58€ • 116.81$ • 92.32£
111.58€ • 116.81$ • 92.32£
Carte tipărită la comandă
Livrare economică 31 martie-14 aprilie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780128019146
ISBN-10: 012801914X
Pagini: 502
Dimensiuni: 191 x 235 x 60 mm
Greutate: 1.2 kg
Editura: ELSEVIER SCIENCE
ISBN-10: 012801914X
Pagini: 502
Dimensiuni: 191 x 235 x 60 mm
Greutate: 1.2 kg
Editura: ELSEVIER SCIENCE
Public țintă
Basic and clinical scientists and practitioners in neuroscience, neurology, immunology, and pharmacologyCuprins
Section I: MS Pathology and Mechanisms
1. MS Pathology: Inflammation versus Neurodegeneration
2. Immune Dysregulation in Multiple Sclerosis
3. CNS immune regulation
4. Genetics of Multiple Sclerosis
5. MS Subtypes: How the Natural History of MS was Challenged Due to Treatment
6. Pediatric-Onset MS as a Window into Early Disease Targets and Mechanisms
7. Sex-related factors in multiple sclerosis
Section II: Other Patho-Mechanisms
8. Environmental Factors and their regulation of immunity in MS
9. Gut Microbiota in Multiple Sclerosis: A Bioreactor driving Brain Autoimmunity
10. Neuroendocrine Checkpoints of Innate Immune Responses in Multiple Sclerosis: Reciprocal Interactions Between Body and Brain
11. Fighting chronic neuroinflammation by boosting autoimmunity: the distinction between neurodegenerative diseases and multiple sclerosis
12. Neuroactive steroids and Neuroinflammation
Section III: Surrogate Markers in Multiple Sclerosis
13. Surrogate Markers in Multiple Sclerosis: The Role of MRI
Section IV: Currently Approved Therapies – Injectable
14. Interferon β in Multiple Sclerosis: A Review
15. Glatiramer Acetate - From Bench to Bed and Back
16. Natalizumab
17. Alemtuzumab (Campath-1H)
18. Currently approved DMDs-injectable: cytotoxic immunosuppressive drugs
Section V: Currently Approved DMDs – Oral
19. Fingolimod (Gilenya)
20. Oral Dimethyl Fumarate (BG-12; Tecfidera®) for Multiple Sclerosis
21. Emerging Therapies for Multiple Sclerosis
Section VI: Symptomatic and Complementary Treatments
22. Treatment of acute relapses in Multiple sclerosis
23. Shedding light on Vitamin D and MS
24. Symptomatic and Complementary Treatments
25. Cognitive Impairment in Multiple Sclerosis
Section VII: Novel and Emerging Strategies
26. Personalized Medicine and Theranostics: Applications to Multiple Sclerosis
27. Stem cell based-therapies, remyelination and repair promotion, in the treatment of multiple sclerosis
28. Stem cells in Multiple Sclerosis
29. T cell vaccination: An insight into T cell regulation
30. Reversal of Misfortune: Therapeutic Strategies on the Horizon
1. MS Pathology: Inflammation versus Neurodegeneration
2. Immune Dysregulation in Multiple Sclerosis
3. CNS immune regulation
4. Genetics of Multiple Sclerosis
5. MS Subtypes: How the Natural History of MS was Challenged Due to Treatment
6. Pediatric-Onset MS as a Window into Early Disease Targets and Mechanisms
7. Sex-related factors in multiple sclerosis
Section II: Other Patho-Mechanisms
8. Environmental Factors and their regulation of immunity in MS
9. Gut Microbiota in Multiple Sclerosis: A Bioreactor driving Brain Autoimmunity
10. Neuroendocrine Checkpoints of Innate Immune Responses in Multiple Sclerosis: Reciprocal Interactions Between Body and Brain
11. Fighting chronic neuroinflammation by boosting autoimmunity: the distinction between neurodegenerative diseases and multiple sclerosis
12. Neuroactive steroids and Neuroinflammation
Section III: Surrogate Markers in Multiple Sclerosis
13. Surrogate Markers in Multiple Sclerosis: The Role of MRI
Section IV: Currently Approved Therapies – Injectable
14. Interferon β in Multiple Sclerosis: A Review
15. Glatiramer Acetate - From Bench to Bed and Back
16. Natalizumab
17. Alemtuzumab (Campath-1H)
18. Currently approved DMDs-injectable: cytotoxic immunosuppressive drugs
Section V: Currently Approved DMDs – Oral
19. Fingolimod (Gilenya)
20. Oral Dimethyl Fumarate (BG-12; Tecfidera®) for Multiple Sclerosis
21. Emerging Therapies for Multiple Sclerosis
Section VI: Symptomatic and Complementary Treatments
22. Treatment of acute relapses in Multiple sclerosis
23. Shedding light on Vitamin D and MS
24. Symptomatic and Complementary Treatments
25. Cognitive Impairment in Multiple Sclerosis
Section VII: Novel and Emerging Strategies
26. Personalized Medicine and Theranostics: Applications to Multiple Sclerosis
27. Stem cell based-therapies, remyelination and repair promotion, in the treatment of multiple sclerosis
28. Stem cells in Multiple Sclerosis
29. T cell vaccination: An insight into T cell regulation
30. Reversal of Misfortune: Therapeutic Strategies on the Horizon
Recenzii
2017 BMA Medical Book Awards Highly Commended in Neurology